After its long-time chief was ousted last year following a proxy battle, Masimo has now appointed a new CEO. | The medtech has tapped Katie Szyman for the role, who served as head of Edwards' critical ...

Q4 2024 Earnings Call Transcript January 22, 2025 Johnson & Johnson beats earnings expectations. Reported EPS is $2.04, ...

As per market research, the respiratory and critical care market in India is valued at Rs 48,500 crores (about $5.8 billion) and is growing at a CAGR of 8.3 ...

FUJIFILM Irvine Scientific, Inc., a global leader in the innovation and manufacture of cell culture solutions for the life science and medical markets, today announced it entered into an agreement to ...

Corilus connects healthcare providers, patients and stakeholders via its cloud-based software and patient app.

The raise was led by Chris O’Brien Lifehouse chief executive and oncologist Michael Boyer and leading orthopedic surgeon ...

From new leadership to product launches, here are five key updates from spine and orthopedic devicemakers since Jan. 15.

Project Stargate will see companies like Oracle, SoftBank, MGX, and OpenAI commit an initial $100 billion to build data ...

Cantor Fitzgerald analyst Ross Osborn increased the 12-month price target on Sanara MedTech shares to $46 from $44, while maintaining an Overweight rating. The adjustment follows Sanara's announcement ...

Ceroflo has a list of well-known backers in the sector and a strong leadership team who worked in Neuravi ...

Johnson & Johnson (J&J) MedTech has reported a 4.8% growth in global sales in 2024, though it expects its 2025 outlook to ...